Stability of an extemporaneously prepared tadalafil suspension

American Journal of Health-System Pharmacy

Volumn 69, Issue 7, 2012, Pages 592-594

  Pettit, Rebecca S ^a   Johnson, Cary E ^b   Caruthers, Regine L ^b  

^a INDIANA UNIVERSITY HEALTH   (United States)

^b Department of Pharmacy Practice   (United States)

Author keywords

Chromatography, liquid; Color; Compounding; Concentration; Hydrogen ion concentration; Odors; Stability; Storage; Suspensions; Tadalafil; Taste; Temperature; Vasodilator agents; Vehicles

Indexed keywords

DRUG VEHICLE; ORA PLUS; ORA SWEET; TADALAFIL; UNCLASSIFIED DRUG;

ARTICLE; DILUTION; DRUG FORMULATION; DRUG MIXTURE; DRUG STABILITY; DRUG STORAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH; PHYSICAL CHEMISTRY; POWDER; PRIORITY JOURNAL; SUSPENSION; TABLET; TASTE;

EID: 84858974953     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110034     Document Type: Article

References (6)

1. Hawkins A, Tulloh R. Treatment of pediatric pulmonary hypertension. Vasc Health Risk Manag. 2009; 5:509-24.
2. Huddleston AJ, Knoderer CA, Morris JL et al. Sildenafil for the treatment of pulmonary hypertension in pediatric patients. Pediatr Cardiol. 2009; 30:871-82.
3. Nahata MC, Morosco RS, Brady MT. Extemporaneous sildenafil citrate oral suspensions for the treatment of pulmonary hypertension in children. Am J Health-Syst Pharm. 2006; 63:254-7. (Pubitemid 43165377)
4. Galie N, Brundage BH, Ghofrani HA et al. Tadalafil therapy for pulmonary arterial hypertension. Circulation. 2009; 119:2894-903.
5. Aboul-Enein HY, Ali I. Determination of tadalafil in pharmaceutical preparation by HPLC using monolithic silica column. Talanta. 2005; 65:276-80.
6. Cheng C, Chou C. Determination of tadalafil in small volumes of plasma by high-performance liquid chromatography with UV detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2005; 822:278-84. (Pubitemid 40994062)